Skip to content

LENZ - LENZ Therapeutics, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchL

LENZ Therapeutics Inc

LENZ · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

L

LENZLENZ Therapeutics Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $50.40
52-wk low: $4.54
Prev close: $27.23
Mkt cap: $154.6M
Beta: 1.63
P/S: 7.2x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$62.3M

SQ
Squarepoint
Q2 2026 13F
$9.9M
position
MI
Millennium
Israel Englander · Q2 2026 13F

Earnings

Reported Jul 29, 2026

Earnings came in 56.2% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $155M

Valuation

P/S7.20
P/B0.68

Quality

Operating margin-623.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: LENZ
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $154.59M
Beta: 1.63

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

0.7x

Profit margin

+0.0%

Op margin

-623.0%

ROE

-59.2%

$8.6M

position

MW

Marshall Wace

Q2 2026 13F

$2.8M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for LENZ

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.53+56.2%

-$1.21 expected

Next report

What the street expects next

-59.2%

ROA-37.4%

Growth

Beta1.63